http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4315024-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72d57b775ebdd5d3f0a7d8cd6232bab1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
filingDate 1980-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1982-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dc6ae081ef904c4e743f896558d4354
publicationDate 1982-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4315024-A
titleOfInvention Compositions and method for treating red eye
abstract A method for treating red eye by administering to the afflicted eye a composition comprising an anti-inflammatory amount of an antagonist for H2 receptors in the eye, preferably cimetidine, and a non-toxic, pharmaceutically acceptable, ophthalmological carrier.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6274160-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8748402-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008285850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005258576-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6225332-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7324689-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372814-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9920265-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7088855-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8073250-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5470849-A
priorityDate 1980-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4220653-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4098898-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3975530-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4112234-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4200760-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4104382-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4013659-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127444069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226710935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128825496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400349
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID58319
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID58319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129119591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753

Total number of triples: 49.